Skip to main content

Weather Alert

Hurricane activity is severely impacting Quest locations across the Southeast. We ask that patients please double check your appointment status to ensure your designated Patient Service Center is operational.

Hide
Quest Diagnostics

AI-Empowered Digital Workflow for Prostate Pathology in Clinical Routine: A Reader Study for Prostate Biopsies

Digital Pathology Association

PathVisions 2023

Orlando, FL, october 19-31, 2023

Oral presentation: AI-Empowered Digital Workflow for Prostate Pathology in Clinical Routine: A Reader Study for Prostate Biopsies

Authors:  Borkowski PA, Dettloff JL, Zhou J, Choi M, Shah S, Loos JT, Rizzo DJ,  Nguyen H-P, Schwab JA, Smail KP, Gutierrez M, Perez LE, Goicouria TR, Fromme S, Piccoli, T Ziv R, Grinwald M, Vecsler M, Wheeler DT

Specialty: Genetics, Oncology

Related content

Publication
A Pilot Feasibility Study of Digital Health Coaching for Men With Prostate Cancer
Audio Podcast
Exploring Digital Pathology and Artificial Intelligence
Publication
Randomized Phase 2 Study of Digital Life Coaching During Transplantation for Myeloma

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.